Article thumbnail

Tuberculosis in Sudan: a study of Mycobacterium tuberculosis strain genotype and susceptibility to anti-tuberculosis drugs

By Ghada S Sharaf Eldin, Imad Fadl-Elmula, Mohammed S Ali, Ahmed B Ali, Abdel Latif GA Salih, Kim Mallard, Christian Bottomley and Ruth McNerney
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2001). AG: Brucellosis among animals and human contacts in eastern Sudan. Saudi Med J
  2. (2003). Bjune G: The effect of decentralisation on tuberculosis services in three states of Sudan. Int J Tuberc Lung Dis
  3. (2006). Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med
  4. (2004). Definition of the Beijing/W lineage of Mycobacterium tuberculosis on the basis of genetic markers.
  5. (2009). ed: Ethnologue: Languages of the World.
  6. (2007). et al: Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis
  7. (2009). et al: Rapid detection of Mycobacterium tuberculosis and rifampin-resistance using on-demand, near patient technology.
  8. (2007). From magic bullets back to the Magic Mountain: the rise of extensively drug-resistant tuberculosis. Nat Med
  9. (2009). Mushtaha : MDR-TB is in town; and might be tugging along XDR-TB. Southern Sudan Medical Journal
  10. (1963). Mycobacteria: Laboratory Methods for Testing Drug Sensitivity and Resistance. Bull World Health Organ
  11. (2008). Okwera A, et al: Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda. Clin Infect Dis
  12. (2008). Organisation: Anti-tuberculosis drug resistance in the world: Report Number 4. The WHO/IUALTD global project on antituberculosis drug resistance surveillance. WHO/CDS/TB/2008394
  13. (2008). Organisation: Global tuberculosis control: surveillance, planning, financing.
  14. (2000). Organisation: Guidelines for Surveillance of drug resistance in tuberculosis.Edited by: Aziz MA.
  15. (2011). Portaels F: Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse Sharaf Eldin et al. BMC Infectious Diseases
  16. (2006). Roring S, et al: Proposal for standardization of optimized mycobacterial interspersed repetitive unitvariable-number tandem repeat typing of Mycobacterium tuberculosis.
  17. (2009). ScreenTape as a tool for the rapid differentiation of Mycobacterium tuberculosis isolates.
  18. (1997). Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology.
  19. South Sudan chosen as name for new country.
  20. (2008). Strengthening TB Drug Management
  21. (2001). Supply P: High-resolution minisatellite-based typing as a portable approach to global analysis of Mycobacterium tuberculosis molecular epidemiology. Proc Natl Acad Sci USA
  22. (2002). TC: Molecular analysis of clinical isolates of Mycobacterium tuberculosis collected from patients with persistent disease in the Khartoum region of Sudan.
  23. (2006). The cost to health services of human immunodeficiency virus (HIV) co-infection among tuberculosis patients in Sudan. Health Policy
  24. (1965). The sensitivity to streptomycin, PAS and isoniazid of strains of Myco. Tuberculosis isolated from patients in Khartoum and Wad Medani. Tubercle
  25. The World Factbook.
  26. (2002). Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int J Tuberc Lung Dis
  27. (2000). Tuberculosis control in Sudan against seemingly insurmountable odds. Int J Tuberc Lung Dis
  28. (2011). Velayati A: Adverse effects of multidrugresistant tuberculosis treatment with a standardized regimen: a report from Iran. Am J Ther
  29. World Development Indicators database. [ ext/ddpreports/ViewSharedReport?
  30. (2010). World Health Organisation: Global tuberculosis control:WHO Report